Qi‐Ying Hu
Research Subjects
Research Interests
Qi‐Ying Hu has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
Huili Zhai
Novartis Institutes for Biomedical Research, 100 Technology Square, Cambridge, MA 02139 (USA)
6 shared publicationsMartin Allan
Novartis Institutes for Biomedical Research, 100 Technology Square, Cambridge, MA 02139 (USA)
6 shared publicationsRoberto Adamo
GSK, Via Fiorentina 1, 53100 Siena (Italy)
5 shared publicationsAimee Usera
Novartis Institutes for Biomedical Research, 100 Technology Square, Cambridge, MA 02139 (USA)
4 shared publicationsAlok Singh
Novartis Institutes for Biomedical Research, 100 Technology Square, Cambridge, MA 02139 (USA)
4 shared publicationsDouglas Quinn
Novartis Institutes for Biomedical Research, 100 Technology Square, Cambridge, MA 02139 (USA)
4 shared publications
Latest Publications
- Open Access
- 21 January 2016
- Published by Royal Society of Chemistry (RSC) in Chemical Society Reviews
- Vol. 45 (6) , 1691-1719
Towards the next generation of biomedicines by site-selective conjugation
Bioconjugates represent an emerging class of medicines, which offer therapeutic opportunities overtaking those of the individual components.
- 21 January 2016
- Published by Royal Society of Chemistry (RSC) in Chemical Society Reviews
- Vol. 45 (6) , 1691-1719
Open AccessTowards the next generation of biomedicines by site-selective conjugation
Bioconjugates represent an emerging class of medicines, which offer therapeutic opportunities overtaking those of the individual components.
- Open Access
- 26 October 2015
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 54 (45)
Frontispiece: Sugar–Protein Connectivity Impacts on the Immunogenicity of Site‐Selective Salmonella O‐Antigen Glycoconjugate Vaccines
- 26 October 2015
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 54 (45)
Open AccessFrontispiece: Sugar–Protein Connectivity Impacts on the Immunogenicity of Site‐Selective Salmonella O‐Antigen Glycoconjugate Vaccines
- 26 October 2015
- Published by Wiley in Angewandte Chemie
- Vol. 127 (45)
Frontispiz: Sugar–Protein Connectivity Impacts on the Immunogenicity of Site‐Selective Salmonella O‐Antigen Glycoconjugate Vaccines
- 26 October 2015
- Published by Wiley in Angewandte Chemie
- Vol. 127 (45)
Frontispiz: Sugar–Protein Connectivity Impacts on the Immunogenicity of Site‐Selective Salmonella O‐Antigen Glycoconjugate Vaccines
- Open Access
- 9 September 2015
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 54 (45) , 13198-13203
Sugar–Protein Connectivity Impacts on the Immunogenicity of Site‐Selective Salmonella O‐Antigen Glycoconjugate Vaccines
A series of glycoconjugates with defined connectivity were synthesized to investigate the impact of coupling Salmonella typhimurium O‐antigen to different amino acids of CRM197 protein carrier. In particular, two novel methods for site‐selective glycan conjugation were developed to obtain conjugates with single attachment site on the protein, based on chemical modification of a disulfide bond and pH‐controlled transglutaminase‐catalyzed modification of lysine, respectively. Importantly, conjugation at the C186‐201 bond resulted in significantly higher anti O‐antigen bactericidal antibody titers than coupling to K37/39, and in comparable titers to conjugates bearing a larger number of saccharides. This study demonstrates that the conjugation site plays a role in determining the immunogenicity in mice and one single attachment point may be sufficient to induce high levels of bactericidal antibodies.
- 9 September 2015
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 54 (45) , 13198-13203
Open AccessSugar–Protein Connectivity Impacts on the Immunogenicity of Site‐Selective Salmonella O‐Antigen Glycoconjugate Vaccines
A series of glycoconjugates with defined connectivity were synthesized to investigate the impact of coupling Salmonella typhimurium O‐antigen to different amino acids of CRM197 protein carrier. In particular, two novel methods for site‐selective glycan conjugation were developed to obtain conjugates with single attachment site on the protein, based on chemical modification of a disulfide bond and pH‐controlled transglutaminase‐catalyzed modification of lysine, respectively. Importantly, conjugation at the C186‐201 bond resulted in significantly higher anti O‐antigen bactericidal antibody titers than coupling to K37/39, and in comparable titers to conjugates bearing a larger number of saccharides. This study demonstrates that the conjugation site plays a role in determining the immunogenicity in mice and one single attachment point may be sufficient to induce high levels of bactericidal antibodies.
- Open Access
- 9 September 2015
- Published by Wiley in Angewandte Chemie
- Vol. 127 (45) , 13396-13401
Sugar–Protein Connectivity Impacts on the Immunogenicity of Site‐Selective Salmonella O‐Antigen Glycoconjugate Vaccines
A series of glycoconjugates with defined connectivity were synthesized to investigate the impact of coupling Salmonella typhimurium O‐antigen to different amino acids of CRM197 protein carrier. In particular, two novel methods for site‐selective glycan conjugation were developed to obtain conjugates with single attachment site on the protein, based on chemical modification of a disulfide bond and pH‐controlled transglutaminase‐catalyzed modification of lysine, respectively. Importantly, conjugation at the C186‐201 bond resulted in significantly higher anti O‐antigen bactericidal antibody titers than coupling to K37/39, and in comparable titers to conjugates bearing a larger number of saccharides. This study demonstrates that the conjugation site plays a role in determining the immunogenicity in mice and one single attachment point may be sufficient to induce high levels of bactericidal antibodies.
- 9 September 2015
- Published by Wiley in Angewandte Chemie
- Vol. 127 (45) , 13396-13401
Open AccessSugar–Protein Connectivity Impacts on the Immunogenicity of Site‐Selective Salmonella O‐Antigen Glycoconjugate Vaccines
A series of glycoconjugates with defined connectivity were synthesized to investigate the impact of coupling Salmonella typhimurium O‐antigen to different amino acids of CRM197 protein carrier. In particular, two novel methods for site‐selective glycan conjugation were developed to obtain conjugates with single attachment site on the protein, based on chemical modification of a disulfide bond and pH‐controlled transglutaminase‐catalyzed modification of lysine, respectively. Importantly, conjugation at the C186‐201 bond resulted in significantly higher anti O‐antigen bactericidal antibody titers than coupling to K37/39, and in comparable titers to conjugates bearing a larger number of saccharides. This study demonstrates that the conjugation site plays a role in determining the immunogenicity in mice and one single attachment point may be sufficient to induce high levels of bactericidal antibodies.
- 21 November 2014
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 25 (12) , 2105-2111
Tyrosine-Directed Conjugation of Large Glycans to Proteins via Copper-Free Click Chemistry
We have demonstrated that the insertion of alkyne-containing bifunctional linkers into the tyrosine residues of the carrier protein, followed by the copper mediated azide–alkyne [3 + 2] cycloaddition of carbohydrates, is a robust approach for the preparation of glycoconjugates with defined glycans, carrier, and connectivity. Conjugation of Group B Streptococcus (GBS) capsular polysaccharides to streptococcal pilus protein could extend the vaccine coverage to a variety of strains. Application of our protocol to these large charged polysaccharides occurred at low yields. Herein we developed a tyrosine-directed conjugation approach based on the copper-free click chemistry of sugars modified with cyclooctynes, which enables efficient condensation of synthetic carbohydrates. Most importantly, this strategy was demonstrated to be more effective than the corresponding copper catalyzed reaction for the insertion of GBS onto the tyrosine residues of GBS pilus proteins, previously selected as vaccine antigens through the so-called reverse vaccinology. Integrity of protein epitopes in the modified proteins was ascertained by competitive ELISA, and conjugation of polysaccharide to protein was confirmed by SDS page electrophoresis and immunoblot assays. The amount of conjugated polysaccharide was estimated by high-performance anion-exchange chromatography coupled with pulsed amperometric detection (HPAEC-PAD). The described technology is particularly suitable for proteins used with the dual role of vaccine antigen and carrier for the carbohydrate haptens.
- 21 November 2014
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 25 (12) , 2105-2111
Tyrosine-Directed Conjugation of Large Glycans to Proteins via Copper-Free Click Chemistry
We have demonstrated that the insertion of alkyne-containing bifunctional linkers into the tyrosine residues of the carrier protein, followed by the copper mediated azide–alkyne [3 + 2] cycloaddition of carbohydrates, is a robust approach for the preparation of glycoconjugates with defined glycans, carrier, and connectivity. Conjugation of Group B Streptococcus (GBS) capsular polysaccharides to streptococcal pilus protein could extend the vaccine coverage to a variety of strains. Application of our protocol to these large charged polysaccharides occurred at low yields. Herein we developed a tyrosine-directed conjugation approach based on the copper-free click chemistry of sugars modified with cyclooctynes, which enables efficient condensation of synthetic carbohydrates. Most importantly, this strategy was demonstrated to be more effective than the corresponding copper catalyzed reaction for the insertion of GBS onto the tyrosine residues of GBS pilus proteins, previously selected as vaccine antigens through the so-called reverse vaccinology. Integrity of protein epitopes in the modified proteins was ascertained by competitive ELISA, and conjugation of polysaccharide to protein was confirmed by SDS page electrophoresis and immunoblot assays. The amount of conjugated polysaccharide was estimated by high-performance anion-exchange chromatography coupled with pulsed amperometric detection (HPAEC-PAD). The described technology is particularly suitable for proteins used with the dual role of vaccine antigen and carrier for the carbohydrate haptens.
- Open Access
- 1 July 2013
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 4 (10) , 3827-3832
Synthesis of a well-defined glycoconjugate vaccine by a tyrosine-selective conjugation strategy
An anti-candidiasis glycoconjugate vaccine was prepared via a tyrosine-selective alkynylation and a click chemistry mediated glycoconjugation sequence. It features a well-defined glycan, protein carrier, and connectivity. The construct, although with significantly lower carbohydrate loading and a shorter β-(1,3) glucan chain than the well-established anti-candidiasis vaccine derived from the random conjugation of laminarin at lysines, elicited a comparable level of specific IgG antibodies.
- 1 July 2013
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 4 (10) , 3827-3832
Open AccessSynthesis of a well-defined glycoconjugate vaccine by a tyrosine-selective conjugation strategy
An anti-candidiasis glycoconjugate vaccine was prepared via a tyrosine-selective alkynylation and a click chemistry mediated glycoconjugation sequence. It features a well-defined glycan, protein carrier, and connectivity. The construct, although with significantly lower carbohydrate loading and a shorter β-(1,3) glucan chain than the well-established anti-candidiasis vaccine derived from the random conjugation of laminarin at lysines, elicited a comparable level of specific IgG antibodies.